Cargando…
Changes observed in radionuclide bone scans during and after teriparatide treatment for osteoporosis
PURPOSE: Visual changes on radionuclide bone scans have been reported with teriparatide treatment. To assess this, serial studies were evaluated and quantified in ten postmenopausal women with osteoporosis treated with teriparatide (20 μg/day subcutaneous) who had (99m)Tc-methylene diphosphonate (MD...
Autores principales: | Moore, Amelia E. B., Blake, Glen M., Taylor, Kathleen A., Ruff, Valerie A., Rana, Asad E., Wan, Xiaohai, Fogelman, Ignac |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261405/ https://www.ncbi.nlm.nih.gov/pubmed/22057627 http://dx.doi.org/10.1007/s00259-011-1974-y |
Ejemplares similares
-
Strontium ranelate: a novel treatment for postmenopausal osteoporosis: a review of safety and efficacy
por: Blake, Glen M, et al.
Publicado: (2006) -
Osteopetrosis: Radiological & Radionuclide Imaging
por: Sit, Cherry, et al.
Publicado: (2015) -
Evaluation of aortic (18)F-NaF tracer uptake using PET/CT as
a predictor of aortic calcification in postmenopausal women: A longitudinal
study
por: Cecelja, Marina, et al.
Publicado: (2019) -
Teriparatide in the management of osteoporosis
por: Bodenner, Donald, et al.
Publicado: (2007) -
Therapy of Osteoporosis in Men with Teriparatide
por: Cusano, Natalie E., et al.
Publicado: (2011)